0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gastrointestinal Drugs Market Research Reports

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
MYTESI Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

MYTESI Market Size, Forecast, and Market Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
EUR$2,750USDGBP
Loperamide Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

Loperamide Market Size, Forecast, and Market Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
EUR$2,750USDGBP
From
EUR$7,950USDGBP
Budesonide Market Size, Forecast, and Drug Insight - 2032 - Product Thumbnail Image

Budesonide Market Size, Forecast, and Drug Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • Global
EUR$3,550USDGBP
Elafibranor Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

Elafibranor Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • Global
EUR$3,550USDGBP
From
EUR$7,950USDGBP
From
EUR$7,500USDGBP
Chemotherapy Induced Diarrhea - Epidemiology Forecast - 2032 - Product Thumbnail Image

Chemotherapy Induced Diarrhea - Epidemiology Forecast - 2032

  • Report
  • February 2023
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
ENTYVIO Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

ENTYVIO Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
EUR$2,750USDGBP
Infliximab-Biosimilars Insight, 2022 - Product Thumbnail Image

Infliximab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 90 Pages
  • Global
From
EUR$2,000USDGBP
Ascites - Epidemiology Forecast - 2032 - Product Thumbnail Image

Ascites - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
From
EUR$7,950USDGBP
From
EUR$7,950USDGBP
From
EUR$7,950USDGBP
From
EUR$7,950USDGBP
From
EUR$4,950USDGBP
From
EUR$4,950USDGBP
From
EUR$3,450USDGBP
Loading Indicator

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists. The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more